| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Dragana Nikolić | Q56246084 |
| Giuseppe Montalto | Q56806930 | ||
| Manfredi Rizzo | Q56862838 | ||
| Dimitri P Mikhailidis | Q62561943 | ||
| P2093 | author name string | Niki Katsiki | |
| Esma Isenovic | |||
| P2860 | cites work | Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development | Q22241480 |
| Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure | Q24611940 | ||
| Atherogenic lipoprotein particles in atherosclerosis | Q28267063 | ||
| Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials | Q28480564 | ||
| Reversal of small, dense LDL subclass phenotype by normalization of adiposity | Q33721993 | ||
| Cardiovascular benefits of bariatric surgery in morbidly obese patients | Q33829180 | ||
| Drug-induced fibrotic valvular heart disease | Q33845974 | ||
| Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. | Q33854891 | ||
| Comparison of a reduced carbohydrate and reduced fat diet for LDL, HDL, and VLDL subclasses during 9-months of weight maintenance subsequent to weight loss | Q33931080 | ||
| Structure of apolipoprotein B-100 in low density lipoproteins. | Q34087902 | ||
| Lipoprotein subfractions and cardiovascular disease risk | Q34119636 | ||
| Years of life lost due to obesity | Q34169086 | ||
| Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study | Q34267056 | ||
| High-density lipoprotein subclasses and their relationship to cardiovascular disease. | Q34322150 | ||
| The effect of insulin resistance and obesity on low-density lipoprotein particle size in children | Q34423197 | ||
| Metabolic origins and clinical significance of LDL heterogeneity | Q34863756 | ||
| Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment | Q35029623 | ||
| Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults | Q47172964 | ||
| Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects | Q47224891 | ||
| Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. | Q47254035 | ||
| Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans | Q47254462 | ||
| Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. | Q47289341 | ||
| Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy. | Q47299647 | ||
| Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults. | Q47411909 | ||
| Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia | Q50233279 | ||
| Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk | Q84962943 | ||
| Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia | Q94529134 | ||
| The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia | Q94700805 | ||
| Fenofibrate: a review of its use in dyslipidaemia | Q95794110 | ||
| Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size | Q35658885 | ||
| Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP) | Q35724113 | ||
| Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy | Q35739667 | ||
| The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects | Q36038038 | ||
| Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases | Q36117824 | ||
| Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol | Q36278478 | ||
| Low-density lipoprotein size and cardiovascular risk assessment. | Q36349994 | ||
| The metabolic basis of atherogenic dyslipidemia | Q36394352 | ||
| Lipid and lipoprotein dysregulation in insulin resistant states | Q36397461 | ||
| Small, dense low-density-lipoproteins and the metabolic syndrome. | Q36642327 | ||
| Exercise, lipids, and lipoproteins in older adults: a meta-analysis | Q36749556 | ||
| Cardiovascular disease under the influence of excess visceral fat. | Q36898584 | ||
| The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes | Q36939789 | ||
| The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials | Q36956730 | ||
| Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women | Q36975580 | ||
| Pathophysiology of obesity: why surgery remains the most effective treatment | Q37000435 | ||
| Effect of obesity on high-density lipoprotein metabolism | Q37058273 | ||
| Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy | Q37063789 | ||
| Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation | Q37134775 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Multiple actions of high-density lipoprotein | Q37180526 | ||
| Cardiorespiratory fitness and adiposity as mortality predictors in older adults. | Q37218505 | ||
| Is it LDL particle size or number that correlates with risk for cardiovascular disease? | Q37244731 | ||
| Atherogenic dyslipidemia and oxidative stress: a new look. | Q37449928 | ||
| Should adipokines be considered in the choice of the treatment of obesity-related health problems? | Q37657578 | ||
| High-density lipoprotein quantity or quality for cardiovascular prevention? | Q37701510 | ||
| Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'? | Q37831334 | ||
| Cilostazol and atherogenic dyslipidemia: a clinically relevant effect? | Q37834033 | ||
| AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types | Q37851958 | ||
| Metabolic and functional relevance of HDL subspecies | Q37871286 | ||
| Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2). | Q37954744 | ||
| Drug treatment of obesity in cardiovascular disease | Q37980171 | ||
| Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? | Q38011522 | ||
| Novel approaches to the pharmacotherapy of obesity | Q38070735 | ||
| Do we need anti-obesity drugs? | Q38071006 | ||
| Low-density lipoprotein sub-fraction profiles in obese children before and after attending a residential weight loss intervention | Q38551907 | ||
| Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. | Q51379451 | ||
| Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. | Q51379457 | ||
| Definition of postprandial lipaemia. | Q51379483 | ||
| Apolipoprotein B48: a novel marker of metabolic risk in overweight children? | Q51471119 | ||
| Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. | Q51493724 | ||
| There is more to predicting vascular disease than just established risk factors. | Q51662237 | ||
| "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. | Q51707131 | ||
| Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. | Q53241071 | ||
| Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. | Q53403417 | ||
| Visceral adiposity and endothelial lipase. | Q53533841 | ||
| Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus. | Q53648322 | ||
| Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity | Q58063473 | ||
| Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria | Q79753613 | ||
| The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome | Q80119876 | ||
| The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome | Q80216746 | ||
| Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes | Q80550171 | ||
| A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity | Q80591466 | ||
| Influence of fatty liver on plasma small, dense LDL- cholesterol in subjects with and without metabolic syndrome | Q82266468 | ||
| The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia | Q82758238 | ||
| Pro-atherogenic postprandial profile: meal-induced changes of lipoprotein sub-fractions and inflammation markers in obese boys | Q83657603 | ||
| "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary | Q84147918 | ||
| Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia | Q84277054 | ||
| Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome | Q84809698 | ||
| Clinical benefits of ezetimibe use: is absence of proof, proof of absence? | Q84932059 | ||
| Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. | Q39978301 | ||
| Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. | Q40012257 | ||
| Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. | Q40022832 | ||
| Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. | Q40485439 | ||
| Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type 2 diabetes. | Q42169796 | ||
| High-Density Lipoprotein Therapy: Is There Hope? | Q42907035 | ||
| Ethnic differences in serum lipoproteins and their determinants in South African women | Q43185533 | ||
| LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality | Q43214909 | ||
| Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity | Q43289570 | ||
| Effect of thiazolidinediones on high-density lipoprotein subfractions | Q43953443 | ||
| Evolution of lipid profiles after bariatric surgery | Q44245043 | ||
| The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. | Q44262558 | ||
| Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes | Q44705128 | ||
| Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia | Q44815352 | ||
| Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women. | Q44816850 | ||
| The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study | Q45070877 | ||
| Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes | Q45250367 | ||
| Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study | Q45250376 | ||
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms | Q45300618 | ||
| Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial | Q45332825 | ||
| A Simple Method for Increasing High-Density Lipoprotein Cholesterol Levels: A Pilot Study of Combination Aerobic and Resistance Exercise Training | Q45347723 | ||
| Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome | Q45722729 | ||
| Effects of atorvastatin on nuclear magnetic resonance-defined lipoprotein subclasses and inflammatory markers in patients with hypercholesterolemia | Q46100095 | ||
| Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia | Q46149589 | ||
| Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial | Q46181203 | ||
| Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis | Q46266488 | ||
| Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. | Q46290681 | ||
| Bariatric surgery improves atherogenic LDL profile by triglyceride reduction | Q46380015 | ||
| Dyslipidemia in visceral obesity: pathophysiological mechanisms, clinical implications and therapy | Q46387504 | ||
| Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome | Q46389694 | ||
| Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factors. | Q46468808 | ||
| LDL size and subclasses in patients with abdominal aortic aneurysm. | Q46681834 | ||
| Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia | Q46721816 | ||
| Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma | Q46751924 | ||
| Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. | Q46777648 | ||
| LDL particle size, fat distribution and insulin resistance in obese children | Q46797451 | ||
| Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia | Q46807918 | ||
| Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle size | Q46824622 | ||
| A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial | Q46879925 | ||
| The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with increased small dense low-density lipoprotein in a rural Japanese population: the Mima study | Q46903448 | ||
| Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
| Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women | Q46956995 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| lipoprotein | Q28350 | ||
| metabolic syndrome | Q657193 | ||
| dyslipidemia | Q66291209 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 928-48 | |
| P577 | publication date | 2013-03-18 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches | |
| P478 | volume | 5 |
| Q90118101 | A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being |
| Q35589319 | Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents |
| Q37317898 | Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography |
| Q39770108 | Analysis of low-density lipoprotein-associated proteins using the method of digitized native protein mapping |
| Q36246734 | Association of Body Mass Index and Body Mass Index Change with Mortality in Incident Peritoneal Dialysis Patients |
| Q36432198 | Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study |
| Q38212026 | Combined effect of plant sterols and dietary fiber for the treatment of hypercholesterolemia |
| Q38385757 | Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program |
| Q47555960 | Correlation between Cholesterol, Triglycerides, Calculated, and Measured Lipoproteins: Whether Calculated Small Density Lipoprotein Fraction Predicts Cardiovascular Risks. |
| Q50180407 | Dyslipidaemia in the elderly: to treat or not to treat? |
| Q45895181 | Effect of atorvastatin on low-density lipoprotein subpopulations and comparison between indicators of plasma atherogenicity: a pilot study |
| Q35122536 | Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients |
| Q47113613 | Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial |
| Q33602145 | Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids |
| Q89972618 | High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation |
| Q38287565 | Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? |
| Q33891946 | Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship? |
| Q54940886 | Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects? |
| Q38231113 | Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan. |
| Q64227549 | PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment |
| Q35222154 | Plasma lipid levels and colorectal adenoma risk |
| Q35556548 | Prevalence of plasma small dense LDL is increased in obesity in a Thai population |
| Q28066150 | Regular-Fat Dairy and Human Health: A Synopsis of Symposia Presented in Europe and North America (2014-2015) |
| Q39949052 | Relationship Between the Apolipoprotein E Genotype and LDL Particle Size in Patients With Obstructive Sleep Apnea |
| Q33717612 | Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. |
| Q61446050 | Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation |
| Q47213196 | The effect of an energy restricted low glycemic index diet on blood lipids, apolipoproteins and lipoprotein (a) among adolescent girls with excess weight: a randomized clinical trial |
| Q92403268 | Two-Hour Postprandial Lipoprotein Particle Concentration Differs Between Lean and Obese Individuals |
Search more.